RevMed's cancer treatment appears inaccessible for certain patients, while the Supreme Court maintains an essential pathway for generic drugs amid ongoing biotech developments.
The pharmaceutical sector is witnessing a series of personnel changes, including new hires, departures, and promotions. Here’s a summary of the latest developments.
The belief in universal health care is strong, yet it raises questions about safety and accountability beyond mere access. Insights from practicing medicine overseas reveal these complexities.
As summer activities like kayaking on the Maquoketa River unfold, concerns about water pollution in Iowa raise health risks and disrupt outdoor enjoyment.
As we reflect on the six-year mark since the onset of the COVID-19 pandemic, experts are evaluating how coordinated responses to domestic violence have evolved during this challenging period.
The Department of Health and Human Services has announced that Americans at high risk of Ebola exposure during the ongoing outbreak in Central Africa will be able to receive an experimental antibody treatment.
A recent presentation on Revolution Medicines' pancreatic cancer drug garnered significant attention, earning a standing ovation. However, the broader biotech sector faced challenges this week.
In a recent late-stage trial, Otsuka's kidney drug Voyxact demonstrated a reduction in the decline of kidney function over one year, but the results did not meet anticipated outcomes.
As RFK Jr. enters his second year as health secretary, he faces significant challenges, including staff vacancies and new regulations that intertwine politics with NIH operations.
This editorial examines the ongoing efforts by the Trump administration to dismantle diversity, equity, and inclusion initiatives and their potential effects on racial health disparities.
Recent findings have revealed a previously unknown location where HIV can remain hidden in the body, raising new questions for treatment strategies.
Despite not yet receiving approval, Revolution Medicines' pancreatic cancer drug is already the subject of discussions regarding its potential expanded applications.
As researchers work on developing treatments and vaccines for hantavirus, recent outbreaks highlight the urgency of their efforts amid limited funding.
Recent monitoring has detected elevated levels of antidepressants in waterways, prompting worries about their potential environmental and health effects.
Stay informed about hantavirus and other health news, including updates on the abortion pill and paternal deaths, as shared in Morning Rounds.
Recent budget cuts to NIH-funded research centers are hindering their ability to maintain crucial relationships with experts needed for effective outbreak responses.
NewLimit, a longevity-focused startup, has successfully raised $435 million in funding, which will support its first clinical trial targeting liver medicine.
Aarhus University researchers are creating a model to improve understanding of soil invertebrates, aligning with the EU's Soil Strategy for 2030.
A recent study suggests that while genetics can influence relationship breakdown, they are not the only factor at play. This insight could inform relationship counseling practices.
This piece outlines the key statutory requirements and policies that have shaped U.S. efforts in global family planning and reproductive health over the years.